Validation of IMPROD biparametric MRI in men with clinically suspected prostate cancer: A prospective multi-institutional trial

Validation of IMPROD biparametric MRI in men with clinically suspected prostate cancer: A prospective multi-institutional trial

<div><p>Background</p><p>Magnetic resonance imaging (MRI) combined with targeted biopsy (TB) is increasingly used in men with clinically suspected prostate cancer (PCa), but the long acquisition times, high costs, and inter-center/reader variability of routine multiparametric...

Full description

Saved in:
Bibliographic Details
Main Author: Ivan Jambor (5701865) (author)
Other Authors: Janne Verho (6791438) (author), Otto Ettala (6791441) (author), Juha Knaapila (6791444) (author), Pekka Taimen (773545) (author), Kari T. Syvänen (6791447) (author), Aida Kiviniemi (835995) (author), Esa Kähkönen (807207) (author), Ileana Montoya Perez (2659849) (author), Marjo Seppänen (6791450) (author), Antti Rannikko (4720587) (author), Outi Oksanen (6791453) (author), Jarno Riikonen (6791456) (author), Sanna Mari Vimpeli (6791459) (author), Tommi Kauko (773546) (author), Harri Merisaari (6791462) (author), Markku Kallajoki (114542) (author), Tuomas Mirtti (155123) (author), Tarja Lamminen (6791465) (author), Jani Saunavaara (6791468) (author), Hannu J. Aronen (6791471) (author), Peter J. Boström (470005) (author)
Published: 2019
Subjects:
Medicine
Cell Biology
Pharmacology
Biotechnology
Developmental Biology
Cancer
Infectious Diseases
Virology
Space Science
SPCa
IMPROD bpMRI findings
biopsy
NPV
Gleason grade group 2
PCa
T 2-weighted imaging
Trial registration ClinicalTrials.gov NCT 02241122
Conclusions IMPROD bpMRI
suspicion
CI
IMPROD biparametric MRI
SB
prostate cancer
multi-institutional trial Background
TB
multiparametric prostate MRI limit
diffusion-weighed imaging acquisitions
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items